Fruquintinib and Sintilimab Treat Advanced Endometrial Cancer
In a groundbreaking advancement in oncological therapeutics, researchers have unveiled a promising new combination therapy targeting advanced endometrial cancer, particularly in patients exhibiting mismatch-repair proficient...
















